NEW YORK (GenomeWeb News) – Precision BioSciences today claimed victory in a lawsuit filed against the company by Cellectis alleging patent infringement.

According to Research Triangle Park, NC-based Precision Bio, a jury in the US District Court for the District of Delaware found all claims of Cellectis' US Patent No. 7,897,372 that were asserted against Precision Bio to be invalid. The jury also found Precision Bio did not "literally" infringe the asserted claims, meaning Precision Bio did not incorporate each and every element of Cellectis' patent in its own technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.